---
layout: post
title: New Drug Approvals 2013 - Pt. XXII - Luliconazole (Luzu ™)
date: '2014-01-14T12:30:00.000Z'
author: Gerard JP van Westen
tags:
- Small Molecule Drugs
- 2013 New Drugs
- Topical Drugs
modified_time: '2014-01-14T14:20:49.545Z'
thumbnail: http://3.bp.blogspot.com/-SjEgQlRpgOY/UtPTt6Xt4LI/AAAAAAAAOmU/m2G2JHhtPwk/s72-c/luliconazole.png
blogger_id: tag:blogger.com,1999:blog-2546008714740235720.post-7468696079537615104
blogger_orig_url: http://chembl.blogspot.com/2014/01/new-drug-approvals-2013-pt-xxii.html
---

<div dir="ltr" style="text-align: left;" trbidi="on">
<div class="separator" style="clear: both; text-align: center;">
<br /></div>
<div class="separator" style="clear: both; text-align: center;">
<br /></div>
<div class="separator" style="clear: both; text-align: center;">
<a href="https://www.ebi.ac.uk/chembltools/autoiconlarge2/1,1,0,1,0,0,0,1,0,1" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" height="41" src="https://www.ebi.ac.uk/chembltools/autoiconlarge2/1,1,0,1,0,0,0,1,0,1" width="400" /></a></div>
<div style="text-align: center;">
<b><br />
</b><b>ATC Code: <a href="http://www.whocc.no/atc_ddd_index/?code=D01AC">D01AC</a>&nbsp;</b><i>(incomplete)</i></div>
<div style="text-align: center;">
<b>Wikipedia:</b>&nbsp;Not Available</div>
<div style="text-align: center;">
<b>ChEMBL:&nbsp;</b><span style="text-align: left;"><a href="https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2105689">CHEMBL2105689</a></span></div>
<br />
<div>
On November 14th the&nbsp;<a href="http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.DrugDetails">FDA approved</a>&nbsp;Luliconazole&nbsp;(trade name Luzu&nbsp;<span style="font-family: Arial, Helvetica, sans-serif; font-size: x-small;"><span style="white-space: nowrap;"><sup>TM</sup></span></span>) for the treatment of skin fungal infections including ringworm. Luliconazole inhibits&nbsp;fungal synthesis of ergosterol, required for fungal cell membranes, by inhibiting&nbsp;the enzyme <a href="http://en.wikipedia.org/wiki/Lanosterol_14_alpha-demethylase">cytochrome P450 14-alpha-demethylase (P45014DM)</a>.<i>&nbsp;</i></div>
<div>
<i><br /></i>
<i><br />
</i> <b>Target(s)</b><br />
Like all azole antifungals, Luliconazole binds and inhibits fungal 14-alpha-demethylase (e.g. <a href="https://www.ebi.ac.uk/chembl/target/inspect/CHEMBL1681624">CHEMBL1681624</a>, Uniprot <a href="http://www.uniprot.org/uniprot/Q96W81">Q96W81</a>).&nbsp;&nbsp;P45014DM is a cytochrome P450 that <a href="http://dx.doi.org/10.1371%2Fjournal.pone.0020973">catalyses the oxidative removal of the 14α-methyl</a> group from&nbsp;eburicol to ergosterol.&nbsp;Azoles <a href="http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0020973">bind to the haem in&nbsp;P45014DM</a>&nbsp;via the unprotonated N atom and occupy the active site as non-competitive inhibitors.<br />
<i><br /></i>
</div>
<div class="separator" style="clear: both; text-align: center;">
<a href="http://3.bp.blogspot.com/-SjEgQlRpgOY/UtPTt6Xt4LI/AAAAAAAAOmU/m2G2JHhtPwk/s1600/luliconazole.png" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" height="320" src="http://3.bp.blogspot.com/-SjEgQlRpgOY/UtPTt6Xt4LI/AAAAAAAAOmU/m2G2JHhtPwk/s320/luliconazole.png" width="320" /></a></div>
<div class="separator" style="clear: both; text-align: center;">
<br /></div>
<div class="separator" style="clear: both; text-align: center;">
<span style="text-align: left;">Luliconazole (</span><span style="text-align: left;"><a href="https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2105689">CHEMBL2105689</a>;&nbsp;</span><span style="text-align: left;">Pubchem :&nbsp;</span><a href="http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?sid=144206495" style="text-align: left;">144206495</a><span style="text-align: left;">&nbsp;) is a small molecule drug with a molecular weight of 354.3 Da, an AlogP of 4.03, 2 rotatable bonds, and no of 5 violations.</span></div>
<div>
<b><br />
</b></div>
<div>
<b>Canonical SMILES</b>&nbsp;: Clc1ccc([C@@H]2CS\C(=C(\C#N)/n3ccnc3)\S2)c(Cl)c1</div>
<b>InChi</b>: InChI=1S/C14H9Cl2N3S2/c15-9-1-2-10(11(16)5-9)13-7-20-14(21-13)12(6-17)19-4-3-18-8-19/h1-5,8,13H,7H2/b14-12+/t13-/m0/s1<br />
<div>
<br /></div>
<div>
<b><br /></b>
<b>Dosage</b></div>
Each gram of Luzu Cream, 1% contains 10 mg of luliconazole in a white cream base.<br />
<br />
For treatment of Interdigital Tinea Pedis:&nbsp;Luzu&nbsp;Cream, 1% should be applied to the affected&nbsp;and immediate surrounding area(s) once a day for two weeks.<br />
<br />
For treatment of&nbsp;Tinea Cruris and Tinea Corporis:&nbsp;Luzu&nbsp;Cream, 1% should be applied to the&nbsp;affected skin and immediate surrounding area(s) once a day for one week.<br />
<div>
<br /></div>
<div>
<br /></div>
<div>
<div>
<b>Drug Interactions</b>&nbsp;</div>
<div>
The potential of luliconazole to inhibit cytochrome P-450 (CYP) enzymes 1A2, 2C9, 2C19, 2D6, and 3A4 was evaluated in vitro. Based on in vitro assessment, luliconazole at therapeutic doses, particularly when applied to patients with moderate to severe Tinea Cruris, may inhibit the activity of CYP2C19 and CYP3A4. However, no in vivo drug interaction trials have been conducted to evaluate the effect of luliconazole on other drugs that are substrates of CYP2C19 and CYP3A4.&nbsp;</div>
</div>
<div>
<br /></div>
<b><i><br /></i></b>
<b>Pregnancy</b><br />
Luliconazole is classified as <a href="http://en.wikipedia.org/wiki/Pregnancy_category">pregnancy category C</a>.&nbsp;Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.<br />
<i><br /></i>
The license holder is <a href="http://www.valeant.com/">Valeant Pharmaceuticals</a>, the highlights of the prescribing information can be found&nbsp;<a href="http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/204153s000lbl.pdf">here</a>.</div>
